<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK458647" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK458647/" /><meta name="ncbi_pagename" content="SATB2-Associated Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SATB2-Associated Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SATB2-Associated Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/10/12" /><meta name="citation_author" content="Yuri A Zarate" /><meta name="citation_author" content="Julie Kaylor" /><meta name="citation_author" content="Jennifer Fish" /><meta name="citation_pmid" content="29023086" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK458647/" /><meta name="citation_keywords" content="2q32 Deletion Syndrome" /><meta name="citation_keywords" content="2q33.1 Microdeletion Syndrome" /><meta name="citation_keywords" content="Glass Syndrome" /><meta name="citation_keywords" content="2q32-q33 Deletion Syndrome" /><meta name="citation_keywords" content="2q32 Deletion Syndrome" /><meta name="citation_keywords" content="2q33 Microdeletion Syndrome" /><meta name="citation_keywords" content="2q33.1 Microdeletion Syndrome" /><meta name="citation_keywords" content="Del(2q32) Syndrome" /><meta name="citation_keywords" content="Glass Syndrome" /><meta name="citation_keywords" content="DNA-binding protein SATB2" /><meta name="citation_keywords" content="SATB2" /><meta name="citation_keywords" content="SATB2-Associated Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SATB2-Associated Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Yuri A Zarate" /><meta name="DC.Contributor" content="Julie Kaylor" /><meta name="DC.Contributor" content="Jennifer Fish" /><meta name="DC.Date" content="2017/10/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK458647/" /><meta name="description" content="SATB2-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited to absent speech, behavioral issues, and craniofacial anomalies. All individuals described to date have manifest developmental delay / intellectual disability, with severe speech delay. Affected individuals often have hypotonia and feeding difficulties in infancy. Behavioral issues may include autistic features, hyperactivity, and aggressiveness. Craniofacial anomalies may include palatal abnormalities (cleft palate, high-arched palate, and bifid uvula), micrognathia, and abnormal shape or size of the upper central incisors. Less common features include skeletal anomalies (osteopenia, pectus deformities, kyphosis/lordosis, and scoliosis), growth restriction, strabismus/refractive errors, congenital heart defects, genitourinary anomalies, and epilepsy. While dysmorphic features have been described in individuals with this condition, these features are not typically distinctive enough to allow for a clinical diagnosis of SAS." /><meta name="og:title" content="SATB2-Associated Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="SATB2-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited to absent speech, behavioral issues, and craniofacial anomalies. All individuals described to date have manifest developmental delay / intellectual disability, with severe speech delay. Affected individuals often have hypotonia and feeding difficulties in infancy. Behavioral issues may include autistic features, hyperactivity, and aggressiveness. Craniofacial anomalies may include palatal abnormalities (cleft palate, high-arched palate, and bifid uvula), micrognathia, and abnormal shape or size of the upper central incisors. Less common features include skeletal anomalies (osteopenia, pectus deformities, kyphosis/lordosis, and scoliosis), growth restriction, strabismus/refractive errors, congenital heart defects, genitourinary anomalies, and epilepsy. While dysmorphic features have been described in individuals with this condition, these features are not typically distinctive enough to allow for a clinical diagnosis of SAS." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK458647/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/satb2-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK458647/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D6D87E04047710000000006B10258.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK458647_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK458647_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/samd9l-ap/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gefs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK458647_"><span class="title" itemprop="name"><i>SATB2-</i>Associated Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: 2q32 Deletion Syndrome, 2q33.1 Microdeletion Syndrome, Glass Syndrome</div><p class="contrib-group"><span itemprop="author">Yuri A Zarate</span>, MD, <span itemprop="author">Julie Kaylor</span>, MS, and <span itemprop="author">Jennifer Fish</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK458647_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK458647_ai__"><div class="contrib half_rhythm"><span itemprop="author">Yuri A Zarate</span>, MD<div class="affiliation small">Section of Genetics and Metabolism<br />University of Arkansas for Medical Sciences<br />Little Rock, Arkansas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.smau@etarazay" class="oemail">ude.smau@etarazay</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Julie Kaylor</span>, MS<div class="affiliation small">Molecular Genetic Pathology<br />Arkansas Children's Hospital<br />Little Rock, Arkansas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcra@ajrolyak" class="oemail">gro.snerdlihcra@ajrolyak</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer Fish</span>, PhD<div class="affiliation small">Department of Biological Sciences<br />University of Massachusetts Lowell<br />Lowell, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.lmu@hsif_refinnej" class="oemail">ude.lmu@hsif_refinnej</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 12, 2017</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="satb2-dis.Summary" itemprop="description"><h2 id="_satb2-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SATB2</i>-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited to absent speech, behavioral issues, and craniofacial anomalies. All individuals described to date have manifest developmental delay / intellectual disability, with severe speech delay. Affected individuals often have hypotonia and feeding difficulties in infancy. Behavioral issues may include autistic features, hyperactivity, and aggressiveness. Craniofacial anomalies may include palatal abnormalities (cleft palate, high-arched palate, and bifid uvula), micrognathia, and abnormal shape or size of the upper central incisors. Less common features include skeletal anomalies (osteopenia, pectus deformities, kyphosis/lordosis, and scoliosis), growth restriction, strabismus/refractive errors, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, genitourinary anomalies, and epilepsy. While <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features have been described in individuals with this condition, these features are not typically distinctive enough to allow for a clinical diagnosis of SAS.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SATB2-</i>associated syndrome (SAS) is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following:</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> intragenic <i>SATB2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (61%)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 2q33.1 that includes <i>SATB2</i> (22%)</div></li><li class="half_rhythm"><div>An intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>SATB2</i> (9%)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with a chromosome 2q33.1 breakpoint that disrupts <i>SATB2</i> (8%)</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic. Nutritional support for feeding difficulties and management by a cleft/craniofacial team for those with palatal anomalies early in life. Early referral for developmental support/special education; standard treatment for dental anomalies, sleep disturbance, skeletal anomalies, seizure disorders, genitourinary anomalies, strabismus and refractive errors, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects.</p><p><i>Surveillance:</i> Evaluation of nutritional status, growth, and developmental progress at each visit; routine monitoring by a neurologist for those with epilepsy; annual sleep study in those with a history of sleep disturbance; evaluation for scoliosis/spine deformity at each visit and consideration of screening for osteopenia; routine evaluations by dentistry and ophthalmology.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SATB2</i>-associated syndrome (SAS) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder. Almost all probands with SAS reported to date have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic event. In two families, parental <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> seemed likely (given recurrence of SAS in sibs and failure to detect the genetic alteration in parental blood samples).To date, individuals with SAS are not known to reproduce. Once an <i>SATB2</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, a 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that includes <i>SATB2</i>, or a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> affecting <i>SATB2</i> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="satb2-dis.Diagnosis"><h2 id="_satb2-dis_Diagnosis_">Diagnosis</h2><p>No formal clinical diagnostic criteria have been established for <i>SATB2</i>-associated syndrome.</p><div id="satb2-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SATB2-</i>associated syndrome (SAS) <b>should be suspected</b> in individuals with the following major features [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>]:</p><ul><li class="half_rhythm"><div>Significant neurodevelopmental disorders in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div><ul><li class="half_rhythm"><div>Infantile hypotonia and feeding difficulties (relatively common)</div></li><li class="half_rhythm"><div>Subsequent developmental delay and severe speech delay (including, in some, absence of speech)</div></li></ul></li><li class="half_rhythm"><div>Behavioral issues: autistic tendencies, hyperactivity, and aggressiveness</div></li><li class="half_rhythm"><div>Palatal anomalies: cleft palate, bifid uvula, and high-arched palate</div></li><li class="half_rhythm"><div>Dental anomalies: prominent upper incisors and other anomalies</div></li></ul><p>Some of the common features can be described using the acronym SATB2: <i>s</i>evere speech anomalies; <i>a</i>bnormalities of the palate, <i>t</i>eeth anomalies, <i>b</i>ehavioral issues with or without <i>b</i>one or <i>b</i>rain anomalies, and onset before age <i>2.</i></p></div><div id="satb2-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SATB2-</i>associated syndrome (SAS) is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following: a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> intragenic <i>SATB2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, a heterozygous non-<a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> at 2q33.1 that includes <i>SATB2</i>, an intragenic deletion or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>SATB2</i> detectable by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA), or a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with a 2q33.1 breakpoint that disrupts <i>SATB2</i> (see <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsatb2disTmoleculargenetictestingus" rid-ob="figobsatb2disTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of CMA, a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>, comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the phenotypes of many inherited disorders with developmental delay / intellectual disability overlap, many children with SAS are diagnosed by the following recommended genomic testing.</p><p><b>Note:</b> Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SAS is indistinguishable from a wide range of other developmental disorders, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> are likely to be diagnosed using <b>CMA</b> and individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> are likely detected by <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequencing</b>.</p><div id="satb2-dis.Recommended_FirstTier_Genomic"><h4>Recommended First-Tier Genomic Testing</h4><p><b>Chromosomal microarray analysis (CMA</b>) using oligonucleotide or SNP arrays is recommended first because deletions/duplications are identified in about 25% of probands (see <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsatb2disTmoleculargenetictestingus" rid-ob="figobsatb2disTmoleculargenetictestingus">Table 1</a>). The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> depends on the type of microarray used and the density of probes in the 2q33.1 region.</p></div><div id="satb2-dis.Options_for_SecondTier_Genomic"><h4>Options for Second-Tier Genomic Testing</h4><p>If a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is not identified on CMA, testing options include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SATB2</i> and other genes of interest (see <a href="#satb2-dis.Differential_Diagnosis">Differential Diagnosis</a>) is recommended because pathogenic sequence variants are identified in 61% of probands (see <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsatb2disTmoleculargenetictestingus" rid-ob="figobsatb2disTmoleculargenetictestingus">Table 1</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsatb2disTmoleculargenetictestingus" rid-ob="figobsatb2disTmoleculargenetictestingus">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when clinically available and not previously performed) including <b><a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a></b> and <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> may be considered.</div><div class="half_rhythm"><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul></div><div id="satb2-dis.Further_Testing_to_Consider"><h4>Further Testing to Consider</h4><p>If a 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is not identified on CMA and an intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified on either a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (genomic sequencing and <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>), additional options for testing include:</p><ul><li class="half_rhythm"><div><b>Karyotype.</b> A <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with a 2q33.1 breakpoint that disrupts <i>SATB2</i> has been observed in 8% of person with SAS (<a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsatb2disTmoleculargenetictestingus" rid-ob="figobsatb2disTmoleculargenetictestingus">Table 1</a>).</div></li></ul><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SATB2,</i> followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><div id="satb2-dis.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SATB2-</i>Associated Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Genetic Alteration&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SATB2</i></td><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">46/76 (61%)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5,6</sup></td><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 7</td></tr><tr><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>8</sup></td><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24/76 (31%)&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype (to detect structural variants)</td><td headers="hd_h_satb2-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/76 (8%)&#x000a0;<sup>10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="satb2-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK458647/#satb2-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="satb2-dis.TF.1.2"><p class="no_margin">See <a href="#satb2-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="satb2-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="satb2-dis.TF.1.4"><p class="no_margin">Almost all individuals with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and frameshift variants have been diagnosed by <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>.</p></div></dd><dt>5. </dt><dd><div id="satb2-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="satb2-dis.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing will detect deletions ranging from a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> to the whole <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>; however, breakpoints of large deletions and/or deletion of adjacent genes may not be detected by these methods.</p></div></dd><dt>7. </dt><dd><div id="satb2-dis.TF.1.7"><p class="no_margin">Note that, although <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> assays may detect smaller events than <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletion/duplication assays, they will detect larger events but may not be able to determine the size. All intragenic deletions and duplications, as well as 2q33.1 deletions, were detected by CMA and would have been detected by a gene-targeted deletion/duplication assay. It is possible that additional smaller deletions and duplications could be detected by these methods.</p></div></dd><dt>8. </dt><dd><div id="satb2-dis.TF.1.8"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays. CMA designs in current clinical use target the 2q33.1 region.</p></div></dd><dt>9. </dt><dd><div id="satb2-dis.TF.1.9"><p class="no_margin">In addition to detecting the 22q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, CMA technology identified an intragenic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in three individuals and an intragenic deletion in four [<a class="bk_pop" href="#satb2-dis.REF.rosenfeld.2009.e6568">Rosenfeld et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.balasubramanian.2011.290">Balasubramanian et al 2011</a>, <a class="bk_pop" href="#satb2-dis.REF.asadollahi.2014.677">Asadollahi et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.lied_n.2014.3083">Lied&#x000e9;n et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.kaiser.2015.704">Kaiser et al 2015</a>].</p></div></dd><dt>10. </dt><dd><div id="satb2-dis.TF.1.10"><p class="no_margin">Six individuals with an <i>SATB2</i> disruption resulting from a "balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>" have been described [<a class="bk_pop" href="#satb2-dis.REF.brewer.1999.387">Brewer et al 1999</a>, <a class="bk_pop" href="#satb2-dis.REF.fitzpatrick.2003.2491">FitzPatrick et al 2003</a>, <a class="bk_pop" href="#satb2-dis.REF.baptista.2008.927">Baptista et al 2008</a>, <a class="bk_pop" href="#satb2-dis.REF.tegay.2009.259">Tegay et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.talkowski.2012.525">Talkowski et al 2012</a>, <a class="bk_pop" href="#satb2-dis.REF.rainger.2014.2569">Rainger et al 2014</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="satb2-dis.Clinical_Characteristics"><h2 id="_satb2-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="satb2-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>SATB2</i>-associated syndrome (SAS) is a multisystem disorder characterized by significant neurodevelopmental compromise with limited or absent speech, behavioral issues, and craniofacial anomalies.</p><p>The following clinical findings, based on published reports of 76 individuals with a molecularly confirmed diagnosis of SAS (47 male, 27 female, 2 where sex was not reported), are summarized in <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.summary_of_the_most_common_c/?report=objectonly" target="object" rid-figpopup="figsatb2disTsummaryofthemostcommonc" rid-ob="figobsatb2disTsummaryofthemostcommonc">Table 2</a> [<a class="bk_pop" href="#satb2-dis.REF.van_buggenhout.2005.276">Van Buggenhout et al 2005</a>, <a class="bk_pop" href="#satb2-dis.REF.leoyklang.2007.732">Leoyklang et al 2007</a>, <a class="bk_pop" href="#satb2-dis.REF.de_ravel.2009.120">de Ravel et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.rosenfeld.2009.e6568">Rosenfeld et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.urquhart.2009.454">Urquhart et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.rifai.2010.111">Rifai et al 2010</a>, <a class="bk_pop" href="#satb2-dis.REF.balasubramanian.2011.290">Balasubramanian et al 2011</a>, <a class="bk_pop" href="#satb2-dis.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#satb2-dis.REF.mc_cormack.2013.823451">Mc Cormack et al 2013</a>, <a class="bk_pop" href="#satb2-dis.REF.tomaszewska.2013.2347">Tomaszewska et al 2013</a>, <a class="bk_pop" href="#satb2-dis.REF.d_cker.2014.1034">D&#x000f6;cker et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.gilissen.2014.344">Gilissen et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.lied_n.2014.3083">Lied&#x000e9;n et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.trakadis.2014.22">Trakadis et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.kaiser.2015.704">Kaiser et al 2015</a>, <a class="bk_pop" href="#satb2-dis.REF.yu.2015.275">Yu et al 2015</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2015.1026">Zarate et al 2015</a>, <a class="bk_pop" href="#satb2-dis.REF.boone.2016.3028">Boone et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.gregoric_kumperscak.2016.395">Gregoric Kumperscak et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.lee.2016.728">Lee et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.schwartz.2017.809">Schwartz et al 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>].</p><div id="satb2-dis.T.summary_of_the_most_common_c" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Summary of the Most Common Clinical Findings in 76 Individuals with <i>SATB2</i>-Associated Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.summary_of_the_most_common_c/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.summary_of_the_most_common_c_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Finding</th><th id="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">% of Affected individuals&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Developmental delay / intellectual disability</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">100%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Speech delay</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">95%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Craniofacial dysmorphism</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">89%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Dental anomalies</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">72%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Behavioral issues</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">55%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Cleft palate</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">50%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Abnormal brain MRI</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">49%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Micrognathia</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">42%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Hypotonia</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">42%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Feeding difficulties</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">39%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Growth restriction</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">34%</td></tr><tr><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Skeletal anomalies</td><td headers="hd_h_satb2-dis.T.summary_of_the_most_common_c_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">32%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="satb2-dis.TF.2.1"><p class="no_margin">Complete information was not available on some individuals.</p></div></dd></dl></div></div></div><p><b>Developmental delay / intellectual disability.</b> While all known individuals with SAS have some degree of intellectual disability, more than half experience severe developmental delay / intellectual disability with absent speech [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>]. For those with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> within <i>SATB2</i> (those who do not have a larger <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 2q33.1 that includes <i>SATB2</i> and other genes), mean age at walking is 20.9 months (range 11-35) and at first word is 19.8 months (range 13-42), although some never achieve verbal communication [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>].</p><p>Developmental regression and/or cognitive decline has been described only once in an adult female with an 8.6-Mb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 2q32.2-q33.1 who progressed from mild to severe intellectual disability and from poor to absent speech between ages six and 12 years [<a class="bk_pop" href="#satb2-dis.REF.gregoric_kumperscak.2016.395">Gregoric Kumperscak et al 2016</a>].</p><p><b>Mild but nonspecific facial dysmorphism.</b> In most reports of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, at least minor facial <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features have been reported. For those with pathogenic variants within <i>SATB2</i>, thin vermilion of the upper lip (20%) and long and smooth philtrum (17%) are the most consistent features (<a class="figpopup" href="/books/NBK458647/figure/satb2-dis.F1/?report=objectonly" target="object" rid-figpopup="figsatb2disF1" rid-ob="figobsatb2disF1">Figure 1 A-E</a>) [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>]. In those with larger 2q33.1 deletions, the most consistent features include prominent forehead or high anterior hairline (53%), thin vermilion of the upper lip (35%), low-set ears (29%), and/or long face (24%) (<a class="figpopup" href="/books/NBK458647/figure/satb2-dis.F1/?report=objectonly" target="object" rid-figpopup="figsatb2disF1" rid-ob="figobsatb2disF1">Figure 1 F-G</a>) [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsatb2disF1" co-legend-rid="figlgndsatb2disF1"><a href="/books/NBK458647/figure/satb2-dis.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figsatb2disF1" rid-ob="figobsatb2disF1"><img class="small-thumb" src="/books/NBK458647/bin/satb2-dis-Image001.gif" src-large="/books/NBK458647/bin/satb2-dis-Image001.jpg" alt="Figure 1. . Facial features of individuals with SATB2-associated syndrome caused by intragenic pathogenic variants in SATB2 (A-D), intragenic deletion of SATB2 (E), and large deletions that include SATB2 and other adjacent genes (F-G)." /></a><div class="icnblk_cntnt" id="figlgndsatb2disF1"><h4 id="satb2-dis.F1"><a href="/books/NBK458647/figure/satb2-dis.F1/?report=objectonly" target="object" rid-ob="figobsatb2disF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Facial features of individuals with <i>SATB2</i>-associated syndrome caused by intragenic pathogenic variants in <i>SATB2</i> (A-D), intragenic deletion of <i>SATB2</i> (E), and large deletions that include <i>SATB2</i> and other adjacent genes (F-G). Most consistently reported <a href="/books/NBK458647/figure/satb2-dis.F1/?report=objectonly" target="object" rid-ob="figobsatb2disF1">(more...)</a></p></div></div><p><b>Dental anomalies.</b> While abnormal shape or size or the upper central incisors is the most common finding (36%), other dental issues can include crowding (36%), hypodontia (16%), delayed primary dentition (6%), and/or diastema (4%). Other issues reported by families include sialorrhea, malocclusion, and fused incisors [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>].</p><p><b>Behavioral anomalies.</b> A broad spectrum of behavioral findings described can include jovial or friendly personality, autistic tendencies, agitation or aggressive outbursts, hyperactivity, difficulties falling asleep or maintaining sleep, and sensory issues [<a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>]. Two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females were described to have Rett syndrome-like phenotypes with limited purposeful hand movements, stereotyped repetitive movements, and bruxism [<a class="bk_pop" href="#satb2-dis.REF.lee.2016.728">Lee et al 2016</a>]. Additional behavioral issues include high pain tolerance, obsessive tendencies, skin picking, and anxiety [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>].</p><p><b>Skeletal anomalies.</b> Pectus deformities, kyphosis/lordosis, and scoliosis have been described in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. To date tibial and/or femoral bowing has been described in a few individuals, some with concurrent osteopenia [<a class="bk_pop" href="#satb2-dis.REF.zarate.2018.588">Zarate et al 2018</a>]. Arachnodactyly, broad thumbs, clinodactyly, small hands/feet, and finger contractures have been infrequently reported.</p><p>While routine screening for osteopenia has not been conducted systematically, low bone mineral density or radiographic evidence of osteopenia has been documented to date in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals as early as age two years [<a class="bk_pop" href="#satb2-dis.REF.leoyklang.2007.732">Leoyklang et al 2007</a>, <a class="bk_pop" href="#satb2-dis.REF.tegay.2009.259">Tegay et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.talkowski.2012.525">Talkowski et al 2012</a>, <a class="bk_pop" href="#satb2-dis.REF.lied_n.2014.3083">Lied&#x000e9;n et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.rainger.2014.2569">Rainger et al 2014</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2015.1026">Zarate et al 2015</a>, <a class="bk_pop" href="#satb2-dis.REF.boone.2016.3028">Boone et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.lee.2016.728">Lee et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2018.588">Zarate et al 2018</a>]. Elevated alkaline phosphatase levels have been seen in some individuals with documented osteopenia [<a class="bk_pop" href="#satb2-dis.REF.boone.2016.3028">Boone et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2018.588">Zarate et al 2018</a>].</p><p><b>Craniofacial anomalies.</b> Palatal abnormalities documented in 76% of individuals include cleft palate (50%), high-arched palate (23%), and bifid uvula (3%). Micrognathia, diagnosed in 42%, has not required surgical correction. The combination of craniofacial issues and hypotonia is the most likely explanation for the high frequency of feeding issues present during infancy and beyond.</p><p><b>Neuroimaging.</b> Brain abnormalities, documented in half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who underwent head MRI, include nonspecific findings such as enlarged ventricles (12%), agenesis of the corpus callosum (5%), and prominent perivascular spaces (5%). Of interest, abnormal myelination for age and/or non-progressive white matter abnormalities appear to be particularly common (26%) in those with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>]. Note that these findings are not sufficiently distinct to specifically suggest the diagnosis of SAS.</p><p><b>Other neurologic manifestations</b></p><ul><li class="half_rhythm"><div>Hypotonia, particularly during infancy (42%)</div></li><li class="half_rhythm"><div>Clinical seizures (14%)</div></li><li class="half_rhythm"><div>EEG abnormalities without clinically recognizable seizures [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>]</div></li><li class="half_rhythm"><div>Less common neurologic issues include gait abnormalities/ataxia (17%), hypertonicity and/or spasticity (4%), and hyperreflexia (3%).</div></li></ul><p><b>Growth restriction.</b> Pre- and postnatal growth restriction, sometimes with associated microcephaly, can be found in individuals with SAS, particularly in those with large deletions involving <i>SATB2</i> and adjacent genes (71%).</p><p><b>Eye findings.</b> Both strabismus (18%) and refractive errors (8%) have been described.</p><p><b>Cardiovascular.</b> Septal defects have been reported in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with large deletions involving <i>SATB2</i> and adjacent genes. In one person, echocardiographic evaluation also revealed severe right ventricular volume overload and persistent pulmonary hypertension [<a class="bk_pop" href="#satb2-dis.REF.van_buggenhout.2005.276">Van Buggenhout et al 2005</a>, <a class="bk_pop" href="#satb2-dis.REF.mc_cormack.2013.823451">Mc Cormack et al 2013</a>].</p><p><b>Genitourinary.</b> Small or undescended testicles, inguinal hernias, and hypospadias have been described in males with large deletions involving <i>SATB2</i> and adjacent genes.</p><p><b>Ectodermal changes.</b> Thin skin, reduced subcutaneous fat, and thin or sparse hair have been described in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with large deletions involving <i>SATB2</i> and adjacent genes.</p></div><div id="satb2-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for <i>SATB2</i> pathogenic variants have been formally established to date; however, it has been suggested that genitourinary anomalies, cardiac defects, and ectodermal changes (other than dental) are more common (or exclusively present) in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with large deletions involving <i>SATB2</i> and adjacent genes [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>].</p><p>The number of reported individuals with SAS is still relatively small; <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> may emerge as more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified.</p></div><div id="satb2-dis.Nomenclature"><h3>Nomenclature</h3><p>The name Glass syndrome was suggested after a report of a male with a cytogenetically visible 2q32.2-q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that included <i>SATB2</i> was published [<a class="bk_pop" href="#satb2-dis.REF.glass.1989.127">Glass et al 1989</a>]. <i>SATB2</i> was subsequently identified as the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with this syndrome [<a class="bk_pop" href="#satb2-dis.REF.fitzpatrick.2003.2491">FitzPatrick et al 2003</a>]. The designation of <i>SATB2</i>-associated syndrome (SAS) was recently proposed as a new clinically recognizable syndrome [<a class="bk_pop" href="#satb2-dis.REF.d_cker.2014.1034">D&#x000f6;cker et al 2014</a>].</p><p>For <i>SATB2</i> alterations, however, the existence of multiple designations for a fairly consistent <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> &#x02012; regardless of the underlying pathomechanism &#x02012; has created some confusion particularly for families of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [Author, personal experience] such that separate social media support groups exist, one for individuals with deletions of <i>SATB2</i> and another for individuals with pathogenic intragenic <i>SATB2</i> variants. In this review, the authors have documented a consistent phenotype independent of the underlying <i>SATB2</i> genetic alteration. When described, phenotypic differences appear to relate (with few exceptions) to differences in severity rather than in the system affected. Therefore, in an attempt to unify the nomenclature and reduce confusion, the authors support use of the term <i>SATB2</i>-associated syndrome.</p></div><div id="satb2-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of SAS is not known. However, two recent studies have estimated the frequency of SAS in large cohorts of individuals with undiagnosed intellectual disability / developmental delay at 0.24%-0.3% [<a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2018.588">Zarate et al 2018</a>].</p></div></div><div id="satb2-dis.Genetically_Related_Allelic_Di"><h2 id="_satb2-dis_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>SATB2</i>.</p></div><div id="satb2-dis.Differential_Diagnosis"><h2 id="_satb2-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>In early infancy the diagnosis of SAS can be particularly difficult to appreciate when developmental delay, hypotonia, feeding difficulties, and palatal issues are the only observable features. During infancy and early childhood, many children with SAS have been tested for Angelman syndrome and related disorders. Over time, the emergence of dental issues and distinctive behavioral issues along with lack of speech progression should lead clinicians to consider this diagnosis. <i>SATB2-</i>associated syndrome should be distinguished from other syndromes that include developmental delay and dental abnormalities, such as KBG syndrome.</p><div id="satb2-dis.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>SATB2</i>-Associated Syndrome (SAS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DD / ID &#x00026;<br />Speech Delay</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniofacial Dysmorphism / Anomalies</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental Anomalies</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behavioral Findings</th><th id="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal/Other</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SATB2</i>-associated syndrome (the subject of this <i>GeneReview</i>)</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SATB2</i></td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Some degree of ID in all known patients; severe DD/ID w/absent speech in ~50%</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least minor facial <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features in most published individuals&#x000a0;<sup>1</sup>.<br />Craniofacial anomalies incl cleft palate, high-arched palate</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most common finding: abnormal shape or size of upper central incisors.<br />Other findings (variably seen): crowding, hypodontia, diastema, delayed primary dentition</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jovial or friendly personality, autistic tendencies, agitation or aggressive outbursts, hyperactivity, sleeping difficulties</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pectus deformities, kyphosis/lordosis, scoliosis, osteopenia</td></tr><tr><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/angelman/">Angelman syndrome</a></td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe DD or ID, severe speech impairment</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically not assoc w/anomalies as seen in SAS</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically not assoc w/findings seen in SAS</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unique behavior w/inappropriate happy demeanor incl frequent laughing, smiling, excitability</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically not assoc w/anomalies seen in SAS</td></tr><tr><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kbgs/">KBG syndrome</a></td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANKRD11</i></td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DD, ID</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features incl triangular face, low anterior &#x00026; posterior hairlines, bushy eyebrows, large prominent ears, anteverted nostrils w/hypoplastic alae nasi.<br />Palatal anomalies not common</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrodontia of upper central incisors</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ASD, ADHD, anxiety, temper tantrums, compulsive &#x00026; aggressive behaviors</td><td headers="hd_h_satb2-dis.T.disorders_to_consider_in_the_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone age often delayed; short stature prevalent; hand anomalies</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; ADHD = attention deficit/hyperactivity disorder; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ASD = autism spectrum disorder; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="satb2-dis.TF.3.1"><p class="no_margin">Consistent features associated with larger 2q33.1 deletions include: prominent forehead or high anterior hairline, thin vermilion of the upper lip, low-set ears, long face. Consistent features associated with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and frameshift variants include: long and flat philtrum and thin vermilion of the upper lip [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>; Author, personal observation].</p></div></dd><dt>2. </dt><dd><div id="satb2-dis.TF.3.2"><p class="no_margin">Angelman syndrome is caused by disruption of maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <i>UBE3A</i> located within the 15q11.2-q13 Angelman syndrome/Prader-Willi syndrome (AS/PWS) region. The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic mechanism leading to the loss of <i>UBE3A</i> function.</p></div></dd></dl></div></div></div></div><div id="satb2-dis.Management"><h2 id="_satb2-dis_Management_">Management</h2><div id="satb2-dis.Evaluations_and_Referrals_Foll"><h3>Evaluations and Referrals Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>SATB2-</i>associated syndrome (SAS), the evaluations summarized in <a class="figpopup" href="/books/NBK458647/table/satb2-dis.T.recommended_evaluations_and/?report=objectonly" target="object" rid-figpopup="figsatb2disTrecommendedevaluationsand" rid-ob="figobsatb2disTrecommendedevaluationsand">Table 4</a> (if not performed as part of the evaluation that led to diagnosis) are recommended:</p><div id="satb2-dis.T.recommended_evaluations_and" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations and Referrals Following Initial Diagnosis of <i>SATB2-</i>Associated Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.recommended_evaluations_and/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.recommended_evaluations_and_lrgtbl__"><table><thead><tr><th id="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Organ System</th><th id="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">W/specific focus on nonverbal language ability</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neuropsychological assessment</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For behavioral problems</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG if seizures suspected</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to neurologist for seizure disorder management</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consider head MRI if seizures present</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Oropharynx</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examination for palatal anomalies</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to craniofacial team or otolaryngologist as needed</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dental, for abnormal tooth shape, number, &#x00026; location</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to dentist</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider videofluoroscopic swallowing study</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Growth (weight, length/height, growth velocity)</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to endocrinologist as needed</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for skeletal anomalies (e.g., scoliosis, kyphosis, tibial bowing)</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to orthopedist as needed</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Assessment for &#x02193; bone mineralization (e.g., recurrent fractures, &#x02191; alkaline phosphatase levels)</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider bone mineral density scan</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For undescended testes, inguinal hernias, &#x00026; hypospadias in males</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology for strabismus &#x00026; refractive errors</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl visual acuity &#x00026; dilated fundus examination</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider echocardiogram</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/larger deletions incl <i>SATB2</i> &#x00026; adjacent genes</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical therapy</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If hypotonia present</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_satb2-dis.T.recommended_evaluations_and_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="satb2-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic; no specific therapy is available. The following are appropriate interventions [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>].</p><div id="satb2-dis.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>SATB2-</i>Associated Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.treatment_of_manifestations_lrgtbl__"><table><thead><tr><th id="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Treatment</th><th id="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay /<br />intellectual disability</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early referral for developmental support / special education</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See text <a href="#satb2-dis.Developmental_Delay__Intellect">following table</a></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental anomalies</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As per routine</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft palate, bifid uvula, micrognathia</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Management by cleft/craniofacial team; surgical correction of cleft palate</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding difficulties</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nutritional support</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to gastroenterologist for those w/persistent issues</td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep disturbance</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep hygiene healthy habits &#x00026; potential medical management as needed</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scoliosis, tibial bowing, joint contractures</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per orthopedist</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Osteopenia</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment remains unclear</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Denosumab used in 1 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> patient, pamidronate infusions used in 2 patients; long-term response to these treatments unknown [<a class="bk_pop" href="#satb2-dis.REF.boone.2016.3028">Boone et al 2016</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2018.588">Zarate et al 2018</a>]</td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seizure disorder</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per neurologist</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Undescended testes, inguinal hernia, hypospadias</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per urologist</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Strabismus &#x00026; refractive error</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per ophthalmologist</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital heart defects</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard therapy per cardiologist</td><td headers="hd_h_satb2-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><div id="satb2-dis.Developmental_Delay__Intellect"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary by country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="satb2-dis.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding and dressing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="satb2-dis.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p></div></div><div id="satb2-dis.Surveillance"><h3>Surveillance</h3><p>Periodic reevaluation by a clinical geneticist to apprise the family of new developments and/or recommendations is suggested. Surveillance may also include the following [<a class="bk_pop" href="#satb2-dis.REF.zarate.2017.327">Zarate &#x00026; Fish 2017</a>]:</p><div id="satb2-dis.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>SATB2-</i>Associated Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.recommended_surveillance_for_lrgtbl__"><table><thead><tr><th id="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency/Comment</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessments</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine intervals to adjust therapies &#x00026; adapt educational needs</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">By neurologist</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per routine for individuals w/epilepsy</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT/Mouth</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dentistry/orthodontics; audiology</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine intervals</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation of nutritional status &#x00026; growth</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sleep study (if history of sleep disturbance)</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for scoliosis &#x00026; spine deformities</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Screening for osteopenia</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology to screen for refractive errors &#x00026; strabismus</td><td headers="hd_h_satb2-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine intervals</td></tr></tbody></table></div></div></div><div id="satb2-dis.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#satb2-dis.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="satb2-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="satb2-dis.Genetic_Counseling"><h2 id="_satb2-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="satb2-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SATB2-</i>associated syndrome (SAS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic alteration.</p></div><div id="satb2-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Almost all probands with SAS reported in the literature to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic alteration (as evidenced by either parental genetic testing or absence of clinical features in the parents).</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of an individual with SAS include genetic testing capable of detecting the <i>SATB2</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, or <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>If the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in either parent, the most likely explanation is that the genetic alteration is a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the proband. Apparent parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has been observed in several families.</div><ul><li class="half_rhythm"><div>A splice variant identified in two brothers with SAS was not detected in the leukocyte DNA of either parent [<a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>].</div></li><li class="half_rhythm"><div>Low-level <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>SATB2</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was detected by <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> in the unaffected father of a child with SAS [Author, unpublished].</div></li><li class="half_rhythm"><div>A 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> (including <i>SATB2</i>) identified in two sibs with SAS was not detected in either parent [Author, unpublished].</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported in the literature to date have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic alteration, suggesting a low risk to sibs. However, the risk to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (see <b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with a 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <i>SATB2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the genetic alteration. Risk to offspring of an individual with a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> depends on the specific structural variant.</div></li><li class="half_rhythm"><div>To date, individuals with SAS are not known to reproduce.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the SAS-related genetic alteration, his or her family members may be at risk.</p></div><div id="satb2-dis.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to the parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="satb2-dis.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the 2q33.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <i>SATB2</i> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Ultrasound examination.</b> Many features of SAS may not be readily identified on ultrasound examination.</p></div></div><div id="satb2-dis.Resources"><h2 id="_satb2-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cleft Palate Foundation (CPF)</b></div><div>1504 East Franklin Street</div><div>Suite 102</div><div>Chapel Hill NC 27514-2820</div><div><b>Phone:</b> 800-242-5338 (toll-free); 919-933-9044</div><div><b>Fax:</b> 919-933-9604</div><div><b>Email:</b> info@cleftline.org</div><div><a href="http://www.cleftline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cleftline.org</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li><li class="half_rhythm"><div><b>Clinical Registry of Individuals with SATB2-Associated Syndrome</b></div><div><b>Email:</b> yazarate@uams.edu</div><div><a href="http://www.satb2gene.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.satb2gene.com</a></div></li></ul></div><div id="satb2-dis.Molecular_Genetics"><h2 id="_satb2-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="satb2-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SATB2-Associated Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_satb2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_satb2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_satb2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_satb2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_satb2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_satb2-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23314" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SATB2</i></a></td><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23314" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q33<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UPW6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DNA-binding protein SATB2</a></td><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SATB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SATB2 @ LOVD</a></td><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SATB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SATB2</a></td><td headers="hd_b_satb2-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SATB2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SATB2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="satb2-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="satb2-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SATB2-Associated Syndrome (<a href="/omim/608148,612313" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608148" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608148</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612313" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612313</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLASS SYNDROME; GLASS</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <i>SATB2</i> transcript variant (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001172509" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001172509</a>) consists of 11 exons and a processed <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript of 5730 bp sequence. Two alternate transcripts, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015265.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015265</a> and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001172517" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001172517</a>, consist of 12 exons with processed mRNAs of 5306 bp and 5326 bp, respectively. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK458647/#satb2-dis.molgen.TA">Table A</a>.</p><p><b>Pathogenic variants.</b> In total, approximately 40 distinct intragenic pathogenic variants have been reported in 46 probands including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>-<a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>. Most variants lead to a premature stop codon and a truncated protein [<a class="bk_pop" href="#satb2-dis.REF.leoyklang.2007.732">Leoyklang et al 2007</a>]. A nonsense variant in the last <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> (p.Glu692Ter) was shown to result in 692-amino-acid C-terminally truncated version of <i>SATB2</i> that escape nonsense-mediated decay [<a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>].</p><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> imbalances resulting from large-scale <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 2q33.1 deletions ranging from 2.4 Mb to 26.3 Mb have been reported.</p><p>Of interest, most reported pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are located in the core of the CUT <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and are expected to result in loss of DNA binding activity given the predicted effect on the helical structure of the domain. [<a class="bk_pop" href="#satb2-dis.REF.bengani.2017.900">Bengani et al 2017</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2017.423">Zarate et al 2017</a>]. A few recurrent variants (p.Arg239Ter, p.Arg283Ter, p.Arg389Cys, p.Arg429Gln, p.Arg459Ter) have been reported.</p><div id="satb2-dis.T.satb2_pathogenic_variants_di" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p><i>SATB2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK458647/table/satb2-dis.T.satb2_pathogenic_variants_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__satb2-dis.T.satb2_pathogenic_variants_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.346+2T&#x0003e;G</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.?</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_3" rowspan="13" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015265.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015265<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/38016202" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056080<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.715C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg239Ter</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.748C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln250Ter</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.847C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg283Ter</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1142T&#x0003e;G</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val381Gly</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1165C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg389Cys</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1171C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln391Ter</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1186G&#x0003e;C</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu396Gln</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1286G&#x0003e;A</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg429Gln</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1375C&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg459Ter</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1945dupT</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser649PhefsTer40</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2018dupA</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His673GlnfsTer16</td></tr><tr><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2074G&#x0003e;T</td><td headers="hd_h_satb2-dis.T.satb2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu692Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SATB2</i> encodes special AT-rich sequence-binding protein 2 (SATB2) a 733-amino-acid protein with two CUT domains and a homeodomain [<a class="bk_pop" href="#satb2-dis.REF.fitzpatrick.2003.2491">FitzPatrick et al 2003</a>]. These functional domains are highly conserved in vertebrates [<a class="bk_pop" href="#satb2-dis.REF.fitzpatrick.2003.2491">FitzPatrick et al 2003</a>, <a class="bk_pop" href="#satb2-dis.REF.sheehanrooney.2010.3481">Sheehan-Rooney et al 2010</a>].</p><p>SATB2 is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> that binds to nuclear matrix-attachment regions (MARs). MARs are DNA regulatory sequences that are involved in chromatin organization and long-range enhancer function. SATB2 binds MARs and activates transcription of multiple genes simultaneously [<a class="bk_pop" href="#satb2-dis.REF.dobreva.2003.3048">Dobreva et al 2003</a>, <a class="bk_pop" href="#satb2-dis.REF.gyorgy.2008.865">Gyorgy et al 2008</a>]. In this context, SATB2 can be considered a master regulator of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> regulatory networks (GRNs) critical to the development of multiple tissues including the jaw, brain, and skeleton &#x02013; tissues <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in humans with SAS [<a class="bk_pop" href="#satb2-dis.REF.britanova.2006.668">Britanova et al 2006</a>, <a class="bk_pop" href="#satb2-dis.REF.dobreva.2006.971">Dobreva et al 2006</a>, <a class="bk_pop" href="#satb2-dis.REF.zarate.2015.1026">Zarate et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Haploinsufficiency of SATB2 causes the SAS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#satb2-dis.REF.rosenfeld.2009.e6568">Rosenfeld et al 2009</a>, <a class="bk_pop" href="#satb2-dis.REF.leoyklang.2013.1383">Leoyklang et al 2013</a>]. In mice, <i>Satb2</i> has been shown to act in a dosage-dependent manner [<a class="bk_pop" href="#satb2-dis.REF.britanova.2006.668">Britanova et al 2006</a>]. Insufficient SATB2 dosage may result in the failure to activate specific genetic programs critical to development. Despite the relatively consistent phenotype of individuals with SAS, variability in the severity of clinical findings has been noted.</p></div><div id="satb2-dis.References"><h2 id="_satb2-dis_References_">References</h2><div id="satb2-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.asadollahi.2014.677">Asadollahi R, Oneda B, Joset P, Azzarello-Burri S, Bartholdi D, Steindl K, Vincent M, Cobilanschi J, Sticht H, Baldinger R, Reissmann R, Sudholt I, Thiel CT, Ekici AB, Reis A, Bijlsma EK, Andrieux J, Dieux A, FitzPatrick D, Ritter S, Baumer A, Latal B, Plecko B, Jenni OG, Rauch A. The clinical significance of small copy number variants in neurodevelopmental disorders. <span><span class="ref-journal">J Med Genet. </span>2014;<span class="ref-vol">51</span>:677–88.</span> [<a href="/pmc/articles/PMC4173859/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4173859</span></a>] [<a href="/pubmed/25106414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25106414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.balasubramanian.2011.290">Balasubramanian M, Smith K, Basel-Vanagaite L, Feingold MF, Brock P, Gowans GC, Vasudevan PC, Cresswell L, Taylor EJ, Harris CJ, Friedman N, Moran R, Feret H, Zackai EH, Theisen A, Rosenfeld JA, Parker MJ. Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:290–8.</span> [<a href="/pubmed/21343628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21343628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.baptista.2008.927">Baptista J, Mercer C, Prigmore E, Gribble SM, Carter NP, Maloney V, Thomas NS, Jacobs PA, Crolla JA. Breakpoint mapping and array CGH in translocations: comparison of a phenotypically normal and an abnormal cohort. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:927–36.</span> [<a href="/pmc/articles/PMC2427237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427237</span></a>] [<a href="/pubmed/18371933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18371933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.bengani.2017.900">Bengani H, Handley M, Alvi M, Ibitoye R, Lees M, Lynch SA, Lam W, Fannemel M, Nordgren A, Malmgren H, Kvarnung M, Mehta S, McKee S, Whiteford M, Stewart F, Connell F, Clayton-Smith J, Mansour S, Mohammed S, Fryer A, Morton J, Grozeva D, Asam T, Moore D, Sifrim A, McRae J, Hurles ME, Firth HV, Raymond FL, Kini U, Nellaker C, FitzPatrick DR, et al.  Clinical and molecular consequences of disease-associated de novo mutations in SATB2. <span><span class="ref-journal">Genet Med. </span>2017;<span class="ref-vol">19</span>:900–8.</span> [<a href="/pmc/articles/PMC5548934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5548934</span></a>] [<a href="/pubmed/28151491" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28151491</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.boone.2016.3028">Boone PM, Chan YM, Hunter JV, Pottkotter LE, Davino NA, Yang Y, Beuten J, Bacino CA. Increased bone turnover, osteoporosis, progressive tibial bowing, fractures, and scoliosis in a patient with a final-exon SATB2 frameshift mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:3028–32.</span> [<a href="/pubmed/27409069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27409069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.brewer.1999.387">Brewer CM, Leek JP, Green AJ, Holloway S, Bonthron DT, Markham AF, FitzPatrick DR. A locus for isolated cleft palate, located on human chromosome 2q32. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:387–96.</span> [<a href="/pmc/articles/PMC1377937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377937</span></a>] [<a href="/pubmed/10417281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10417281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.britanova.2006.668">Britanova O, Depew MJ, Schwark M, Thomas BL, Miletich I, Sharpe P, Tarabykin V. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:668–78.</span> [<a href="/pmc/articles/PMC1592575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1592575</span></a>] [<a href="/pubmed/16960803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16960803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.de_ravel.2009.120">de Ravel TJ, Balikova I, Thiry P, Vermeesch JR, Frijns JP. Another patient with a de novo deletion further delineates the 2q33.1 microdeletion syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2009;<span class="ref-vol">52</span>:120–2.</span> [<a href="/pubmed/19284984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19284984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.dobreva.2006.971">Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Farinas I, Karsenty G, Grosschedl R. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">125</span>:971–86.</span> [<a href="/pubmed/16751105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16751105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.dobreva.2003.3048">Dobreva G, Dambacher J, Grosschedl R. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. <span><span class="ref-journal">Genes Dev. </span>2003;<span class="ref-vol">17</span>:3048–61.</span> [<a href="/pmc/articles/PMC305257/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC305257</span></a>] [<a href="/pubmed/14701874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14701874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.d_cker.2014.1034">D&#x000f6;cker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, Bartholdi D. Further delineation of the SATB2 phenotype. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:1034–9.</span> [<a href="/pmc/articles/PMC4350596/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4350596</span></a>] [<a href="/pubmed/24301056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24301056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.fitzpatrick.2003.2491">FitzPatrick DR, Carr IM, McLaren L, Leek JP, Wightman P, Williamson K, Gautier P, McGill N, Hayward C, Firth H, Markham AF, Fantes JA, Bonthron DT. Identification of SATB2 as the cleft palate gene on 2q32-q33. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:2491–501.</span> [<a href="/pubmed/12915443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12915443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.gilissen.2014.344">Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, Kwint M, Janssen IM, Hoischen A, Schenck A, Leach R, Klein R, Tearle R, Bo T, Pfundt R, Yntema HG, de Vries BB, Kleefstra T, Brunner HG, Vissers LE, Veltman JA. Genome sequencing identifies major causes of severe intellectual disability. <span><span class="ref-journal">Nature. </span>2014;<span class="ref-vol">511</span>:344–7.</span> [<a href="/pubmed/24896178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24896178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.glass.1989.127">Glass IA, Swindlehurst CA, Aitken DA, McCrea W, Boyd E. Interstitial deletion of the long arm of chromosome 2 with normal levels of isocitrate dehydrogenase. <span><span class="ref-journal">J Med Genet. </span>1989;<span class="ref-vol">26</span>:127–30.</span> [<a href="/pmc/articles/PMC1015564/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015564</span></a>] [<a href="/pubmed/2918541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2918541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.gregoric_kumperscak.2016.395">Gregoric Kumperscak H, Krgovic D, Vokac NK. Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1. <span><span class="ref-journal">J Int Med Res. </span>2016;<span class="ref-vol">44</span>:395–402.</span> [<a href="/pmc/articles/PMC5580054/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5580054</span></a>] [<a href="/pubmed/26811410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26811410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.gyorgy.2008.865">Gyorgy AB, Szemes M, de Juan Romero C, Tarabykin V, Agoston DV. SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. <span><span class="ref-journal">Eur J Neurosci. </span>2008;<span class="ref-vol">27</span>:865–73.</span> [<a href="/pubmed/18333962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18333962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.kaiser.2015.704">Kaiser AS, Maas B, Wolff A, Sutter C, Janssen JW, Hinderhofer K, Moog U. Characterization of the first intragenic SATB2 duplication in a girl with intellectual disability, nearly absent speech and suspected hypodontia. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:704–7.</span> [<a href="/pmc/articles/PMC4402638/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4402638</span></a>] [<a href="/pubmed/25118029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25118029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.lee.2016.728">Lee JS, Yoo Y, Lim BC, Kim KJ, Choi M, Chae JH. SATB2-associated syndrome presenting with Rett-like phenotypes. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">89</span>:728–32.</span> [<a href="/pubmed/26596517" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26596517</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.leoyklang.2007.732">Leoyklang P, Suphapeetiporn K, Siriwan P, Desudchit T, Chaowanapanja P, Gahl WA, Shotelersuk V. Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:732–8.</span> [<a href="/pubmed/17377962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17377962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.leoyklang.2013.1383">Leoyklang P, Suphapeetiporn K, Srichomthong C, Tongkobpetch S, Fietze S, Dorward H, Cullinane AR, Gahl WA, Huizing M, Shotelersuk V. Disorders with similar clinical phenotypes reveal underlying genetic interaction: SATB2 acts as an activator of the UPF3B gene. <span><span class="ref-journal">Hum Genet. </span>2013;<span class="ref-vol">132</span>:1383–93.</span> [<a href="/pmc/articles/PMC4160176/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4160176</span></a>] [<a href="/pubmed/23925499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23925499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.lied_n.2014.3083">Lied&#x000e9;n A, Kvarnung M, Nilsson D, Sahlin E, Lundberg ES. Intragenic duplication--a novel causative mechanism for SATB2-associated syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:3083–7.</span> [<a href="/pubmed/25251319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25251319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.mc_cormack.2013.823451">Mc Cormack A, Taylor J, Gregersen N, George AM, Love DR. Delineation of 2q32q35 deletion phenotypes: two apparent "proximal" and "distal" syndromes. <span><span class="ref-journal">Case Rep Genet. </span>2013;<span class="ref-vol">2013</span>:823451.</span> [<a href="/pmc/articles/PMC3690635/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3690635</span></a>] [<a href="/pubmed/23840981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23840981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.rainger.2014.2569">Rainger JK, Bhatia S, Bengani H, Gautier P, Rainger J, Pearson M, Ansari M, Crow J, Mehendale F, Palinkasova B, Dixon MJ, Thompson PJ, Matarin M, Sisodiya SM, Kleinjan DA, Fitzpatrick DR. Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:2569–79.</span> [<a href="/pmc/articles/PMC3990159/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3990159</span></a>] [<a href="/pubmed/24363063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24363063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.rauch.2012.1674">Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. <span><span class="ref-journal">Lancet. </span>2012;<span class="ref-vol">380</span>:1674–82.</span> [<a href="/pubmed/23020937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23020937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.rifai.2010.111">Rifai L, Port-Lis M, Tabet AC, Bailleul-Forestier I, Benzacken B, Drunat S, Kuzbari S, Passemard S, Verloes A, Aboura A. Ectodermal dysplasia-like syndrome with mental retardation due to contiguous gene deletion: further clinical and molecular delineation of del(2q32) syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:111–7.</span> [<a href="/pubmed/20034071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20034071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.rosenfeld.2009.e6568">Rosenfeld JA, Ballif BC, Lucas A, Spence EJ, Powell C, Aylsworth AS, Torchia BA, Shaffer LG. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e6568.</span> [<a href="/pmc/articles/PMC2719055/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2719055</span></a>] [<a href="/pubmed/19668335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19668335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.schwartz.2017.809">Schwartz E, Wilkens A, Noon SE, Krantz ID, Wu Y. A de novo SATB2 mutation in monozygotic twins with cleft palate, dental anomalies, and developmental delay. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:809–12.</span> [<a href="/pubmed/28211976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28211976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.sheehanrooney.2010.3481">Sheehan-Rooney K, Palinkasova B, Eberhart JK, Dixon MJ. A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages. <span><span class="ref-journal">Dev Dyn. </span>2010;<span class="ref-vol">239</span>:3481–91.</span> [<a href="/pmc/articles/PMC3058410/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3058410</span></a>] [<a href="/pubmed/21089028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21089028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.talkowski.2012.525">Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, Ernst C, Hanscom C, Rossin E, Lindgren AM, Pereira S, Ruderfer D, Kirby A, Ripke S, Harris DJ, Lee JH, Ha K, Kim HG, Solomon BD, Gropman AL, Lucente D, Sims K, Ohsumi TK, Borowsky ML, Loranger S, Quade B, Lage K, Miles J, Wu BL, Shen Y, Neale B, Shaffer LG, Daly MJ, Morton CC, Gusella JF. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">149</span>:525–37.</span> [<a href="/pmc/articles/PMC3340505/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3340505</span></a>] [<a href="/pubmed/22521361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22521361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.tegay.2009.259">Tegay DH, Chan KK, Leung L, Wang C, Burkett S, Stone G, Stanyon R, Toriello HV, Hatchwell E. Toriello-Carey syndrome in a patient with a de novo balanced translocation [46,XY,t(2;14)(q33;q22)] interrupting SATB2. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:259–64.</span> [<a href="/pubmed/19170718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19170718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.tomaszewska.2013.2347">Tomaszewska A, Podbiol-Palenta A, Boter M, Geisler G, Wawrzkiewicz-Witkowska A, Galjaard RJ, Zajaczek S, Srebniak MI. Deletion of 14.7 Mb 2q32.3q33.3 with a marfanoid phenotype and hypothyroidism. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2347–51.</span> [<a href="/pubmed/23918240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23918240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.trakadis.2014.22">Trakadis YJ, Buote C, Therriault JF, Jacques PE, Larochelle H, Levesque S. PhenoVar: a phenotype-driven approach in clinical genomics for the diagnosis of polymalformative syndromes. <span><span class="ref-journal">BMC Med Genomics. </span>2014;<span class="ref-vol">7</span>:22.</span> [<a href="/pmc/articles/PMC4030287/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4030287</span></a>] [<a href="/pubmed/24884844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24884844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.urquhart.2009.454">Urquhart J, Black GC, Clayton-Smith J. 4.5 Mb microdeletion in chromosome band 2q33.1 associated with learning disability and cleft palate. <span><span class="ref-journal">Eur J Med Genet. </span>2009;<span class="ref-vol">52</span>:454–7.</span> [<a href="/pubmed/19576302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19576302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.van_buggenhout.2005.276">Van Buggenhout G, Van Ravenswaaij-Arts C, Mc Maas N, Thoelen R, Vogels A, Smeets D, Salden I, Matthijs G, Fryns JP, Vermeesch JR. The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients. <span><span class="ref-journal">Eur J Med Genet. </span>2005;<span class="ref-vol">48</span>:276–89.</span> [<a href="/pubmed/16179223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16179223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.yu.2015.275">Yu N, Shin S, Lee KA. First Korean case of SATB2-associated 2q32-q33 microdeletion syndrome. <span><span class="ref-journal">Ann Lab Med. </span>2015;<span class="ref-vol">35</span>:275–8.</span> [<a href="/pmc/articles/PMC4330186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4330186</span></a>] [<a href="/pubmed/25729738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25729738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.zarate.2017.327">Zarate YA, Fish JL. SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:327–37.</span> [<a href="/pmc/articles/PMC5297989/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5297989</span></a>] [<a href="/pubmed/27774744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27774744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.zarate.2017.423">Zarate YA, Kalsner L, Basinger A, Jones JR, Li C, Szybowska M, Xu ZL, Vergano S, Caffrey AR, Gonzalez CV, Dubbs H, Zackai E, Millan F, Telegrafi A, Baskin B, Person R, Fish JL, Everman DB. Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:423–9.</span> [<a href="/pubmed/28139846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28139846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.zarate.2015.1026">Zarate YA, Perry H, Ben-Omran T, Sellars EA, Stein Q, Almureikhi M, Simmons K, Klein O, Fish J, Feingold M, Douglas J, Kruer MC, Si Y, Mao R, McKnight D, Gibellini F, Retterer K, Slavotinek A. Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:1026–32.</span> [<a href="/pubmed/25885067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25885067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="satb2-dis.REF.zarate.2018.588">Zarate YA, Steinraths M, Matthews A, Smith W, Sun A, Wilson LC, Brain C, Allgove J, Jacobs B, Fish JL, Powell CM, Wasserman W, Van Karnebeek C, Wakeling EL, Ma NS. Bone health and SATB2-associated syndrome. <span><span class="ref-journal">Clin Genet. </span>2018;<span class="ref-vol">93</span>:588–94.</span> [<a href="/pubmed/28787087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28787087</span></a>]</div></li></ul></div></div><div id="satb2-dis.Chapter_Notes"><h2 id="_satb2-dis_Chapter_Notes_">Chapter Notes</h2><div id="satb2-dis.Author_Notes"><h3>Author Notes</h3><p>Website dedicated to <i>SATB2</i>-associated syndrome (SAS): <a href="http://www.satb2gene.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.satb2gene.com</a></p></div><div id="satb2-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 October 2017 (ma) Review posted live</div></li><li class="half_rhythm"><div>19 December 2016 (yaz) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK458647</span><span class="label">PMID: <a href="/pubmed/29023086" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29023086</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/samd9l-ap/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gefs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK458647&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK458647/?report=reader">PubReader</a></li><li><a href="/books/NBK458647/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK458647" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK458647" style="display:none" title="Cite this Page"><div class="bk_tt">Zarate YA, Kaylor J, Fish J. SATB2-Associated Syndrome. 2017 Oct 12. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK458647/pdf/Bookshelf_NBK458647.pdf">PDF version of this page</a> (1.0M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#satb2-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#satb2-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#satb2-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#satb2-dis.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#satb2-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#satb2-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#satb2-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#satb2-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#satb2-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#satb2-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#satb2-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23314[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SATB2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4455130" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4455130" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4455130" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4455130" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301487" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301696" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald-McGinn DM, Emanuel BS, Zackai EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301585" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mowat-Wilson Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mowat-Wilson Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adam MP, Conta J, Bean LJH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29023086" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29023086" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041486dd21425a25dba1a0">SATB2-Associated Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SATB2-Associated Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:01:42-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D6D87E04047710000000006B10258&amp;ncbi_session=CE8D6D87E0414851_1713SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK458647%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK458647&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK458647/&amp;ncbi_pagename=SATB2-Associated Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D6D87E0414851_1713SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>